Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag as a frontline therapy show significantly improved platelet responses and other outcomes compared with the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback